Investigating patient support usage and perceptions
UCB Pharma required a market research study that investigated usage and perceptions of patient support programmes in different EU markets and to explore what an ideal solution might look like.
UCB Pharma required a market research study that investigated usage and perceptions of patient support programmes in different EU markets and to explore what an ideal solution might look like.
A large-scale international research patient study was conducted by Turquoise across the UK, Germany, Italy, France and Spain with sufferers of a number of conditions. A number of these conditions were extremely niche and challenging requiring our experience on which international panels to access for optimum results.
In addition to the online patient research, an online survey was also conducted with a number of key HCP audiences in both Germany and the UK.
The results have highlighted how patients currently experience these patient support programmes and how UCB would need to refine and supplement their offering across each market. The outputs of this study are now being implemented across each market.
Our unique approach
Whether we are helping pharmaceutical companies understand and predict patient behaviour, powering smarter data-driven strategy, or driving organisational change, our unique model helps deliver scientifically superior results for the whole industry.
Know what consumers think, better than they know themselves. Our model uniquely unearths subconscious psychological factors that influence customer feelings and behaviours.
Our model validates deeper methodological and contextual factors behind the data, not just the data itself, which helps uncover truly relevant insight while minimising noise.
Our unique model allows pharmaceutical companies to accurately predict market and customer behaviour, helping to power genuinely forward-thinking strategy and decision making.
